The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


APH ALLIANCE PHARMA PLC ORD 1P

ALLIANCE PHARMA  Currency  GBX 


Income Statement  (£ m) 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Continuing Operations
Revenue  43.54 45.28 44.90 45.96 49.88
Operating Profit/(Loss)  11.17 13.31 12.32 12.34 16.97
Net Interest  0.99 1.26 1.52 1.57 2.20
Profit Before Tax  10.16 12.01 10.81 10.71 12.87
Profit After Tax  8.39 9.58 8.69 8.64 8.95
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  8.39 9.58 8.69 8.64 8.95
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  8.39 9.58 8.69 8.64 8.95
 
Continuing EPS
Earnings per Share - Basic  3.17p 3.82p 3.61p 3.62p 3.96p
Earnings per Share - Diluted  3.16p 3.68p 3.40p 3.39p 3.64p
Earnings per Share - Adjusted  3.36p 3.82p 3.61p 3.62p 5.07p
Continuing and Discontinued EPS
Earnings per Share - Basic  3.17p 3.82p 3.61p 3.62p 3.96p
Earnings per Share - Diluted  3.16p 3.68p 3.40p 3.39p 3.64p
Earnings per Share - Adjusted  3.36p 3.82p 3.61p 3.62p 5.07p
 
Dividend per Share  0.91p 0.83p 0.75p 0.57p 0.30p

Balance Sheet  (£ m) 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Assets
Non-Current Assets
Property, Plant & Equipment  0.40 0.59 0.49 0.77 0.89
Intangible Assets  88.88 87.11 79.89 66.13 60.29
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  1.27 0.53 0.00 0.00 0.00
Other Financial Assets  0.00 0.44 0.00 0.00 0.00
Other Non-Current Assets  1.66 1.46 0.08 0.00 0.00
  92.20 90.14 80.45 66.90 61.18
Current Assets
Inventories  5.91 5.47 5.39 5.65 4.54
Trade & Other Receivables  8.32 10.64 10.15 8.66 9.69
Cash at Bank & in Hand  1.43 0.69 4.63 1.08 1.99
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  15.67 16.80 20.17 15.39 16.22
 
Total Assets  107.87 106.94 100.63 82.29 77.40
 
Liabilities
Current Liabilities
Borrowings  -3.31 -5.02 -10.44 -4.25 -4.00
Other Current Liabilities  -8.11 -9.88 -11.61 -9.61 -12.98
  -11.42 -14.90 -22.05 -13.86 -16.98
 
Net Current Assets  4.26 1.90 -1.87 1.53 -0.76
 
Non-Current Liabilities
Borrowings  -19.24 -20.88 -20.23 -19.69 -19.82
Provisions  -6.31 -6.49 -6.49 -4.57 -4.44
Other Non-Current Liabilities  -0.13 0.00 -0.02 -0.04 -0.07
  -25.67 -27.37 -26.73 -24.30 -24.34
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -37.09 -42.27 -48.78 -38.16 -41.32
 
Net Assets  70.78 64.67 51.85 44.13 36.08
 
Capital & Reserves
Share Capital  2.64 2.64 2.43 2.40 2.36
Share Premium Account  29.39 29.38 25.30 24.87 24.33
Other Reserves  1.56 1.45 0.46 0.09 -0.11
Retained Earnings  37.19 31.20 23.66 16.77 9.49
Shareholders Funds  70.78 64.67 51.85 44.13 36.08
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  70.78 64.67 51.85 44.13 36.08

Ratios - based on IFRS 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Continuing Operations
PE Ratio - Adjusted  10.86 10.60 8.80 8.53 6.11
PEG - Adjusted  -0.90 1.82 -31.43 -0.30 0.14
Earnings per Share Growth - Adjusted  -12.04% 5.82% -0.28% -28.60% 42.82%
Dividend Cover  3.70 4.63 4.81 6.35 16.90
Revenue Per Share  16.48p 18.05p 18.64p 19.26p 22.06p
Pre-Tax Profit per Share  3.85p 4.79p 4.49p 4.49p 5.69p
Operating Margin  24.75% 29.30% 27.45% 26.72% 30.21%
Return on Capital Employed  103.58% 133.33% 135.28% 188.74% 371.21%
 
Continuing & Discontinued Operations
Dividend Yield  2.49% 2.04% 2.36% 1.85% 0.97%
Dividend per Share Growth  10.06% 10.00% 31.58% 90.00% n/a
Net Asset Value per Share (exc. Intangibles)  -6.85p -8.50p -11.54p -9.19p -10.25p
Net Gearing  29.82% 38.99% 50.20% 51.79% 60.51%

Data is provided by Morningstar


ALLIANCE PHARMA share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds